Hiroshi Tanaka
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Epidemiology top 10%
- Molecular Biology
- Cancer Research top 10%
- Co-authors
- Kaoru MogushiToyoaki HidaKazuhiko NakagawaTomohide TamuraYuichiro OheMakoto NishioMiyako SatouchiFengrong Ren
- Topics
- Lung Cancer Treatments and Mutations (24 papers)Cancer Immunotherapy and Biomarkers (19 papers)Pancreatic and Hepatic Oncology Research (15 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Hiroshi Tanaka
89 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 102
- Oncology 772
- Pulmonary and Respiratory Medicine 519
- Epidemiology 315
- Molecular Biology 303
- Cancer Research 183
Countries citing papers authored by Hiroshi Tanaka
This map shows the geographic impact of Hiroshi Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tanaka more than expected).
Fields of papers citing papers by Hiroshi Tanaka
This network shows the impact of papers produced by Hiroshi Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tanaka. The network helps show where Hiroshi Tanaka may publish in the future.
Co-authorship network of co-authors of Hiroshi Tanaka
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tanaka. A scholar is included among the top collaborators of Hiroshi Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tanaka. Hiroshi Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 4 | |
| 9 | 14 | |
| 10 | 41 | |
| 11 | 135 | |
| 12 | 14 | |
| 13 | 10 | |
| 14 | 10 | |
| 15 | 6 | |
| 16 | 13 | |
| 17 | 87 | |
| 18 | [Ten cases of advanced gastro-intestinal cancer that required preoperative dosage of PSK]. | 1 |
| 19 | 97 | |
| 20 | Dialysis therapy in the 1990s | 1 |
About Hiroshi Tanaka
Hiroshi Tanaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology, having authored 96 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (24 papers), Cancer Immunotherapy and Biomarkers (19 papers) and Pancreatic and Hepatic Oncology Research (15 papers). The work is most often cited by research in Oncology (772 citations), Hepatology (175 citations) and Pulmonary and Respiratory Medicine (519 citations). Hiroshi Tanaka has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Kaoru Mogushi, Toyoaki Hida, Kazuhiko Nakagawa, Tomohide Tamura, Yuichiro Ohe, Makoto Nishio, Miyako Satouchi, Fengrong Ren, Kenji Ikeda and Satoru Nakata. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.